Viatris, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92556V1061
  • NASDAQ: MYL
USD
17.18
0.08 (0.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Incyte Corp.
Viatris, Inc.
Alnylam Pharmaceuticals, Inc.
Bristol Myers Squibb Co.
Vertex Pharmaceuticals, Inc.
Zoetis, Inc.
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc.
Horizon Therapeutics Plc
Seagen Inc.

Why is Viatris, Inc. ?

1
With a growth in Operating Profit of 21.07%, the company declared Outstanding results in Jun 26
  • The company has declared positive results for the last 2 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 2,330.8 MM
  • ROCE(HY) Highest at -2.75%
  • INTEREST COVERAGE RATIO(Q) Highest at 959.27
2
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 6.26% over the previous quarter.
3
Market Beating Performance
  • The stock has generated a return of 75.49% in the last 1 year, much higher than market (S&P 500) returns of 16.00%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Viatris, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Viatris, Inc. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Viatris, Inc.
75.49%
1.94
32.63%
S&P 500
16.0%
1.22
13.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.66%
EBIT Growth (5y)
26.40%
EBIT to Interest (avg)
2.84
Debt to EBITDA (avg)
3.97
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
0.44
Tax Ratio
3.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
93.74%
ROCE (avg)
4.26%
ROE (avg)
5.48%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.04
EV to EBIT
24.89
EV to EBITDA
7.21
EV to Capital Employed
1.02
EV to Sales
1.99
PEG Ratio
NA
Dividend Yield
84.69%
ROCE (Latest)
4.11%
ROE (Latest)
-0.46%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

29What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 2,330.8 MM

ROCE(HY)

Highest at -2.75%

INTEREST COVERAGE RATIO(Q)

Highest at 959.27

PRE-TAX PROFIT(Q)

Highest at USD 421.9 MM

NET PROFIT(Q)

At USD 367.1 MM has Grown at 126.47%

RAW MATERIAL COST(Y)

Fallen by -6.9% (YoY

CASH AND EQV(HY)

Highest at USD 3,670.7 MM

NET SALES(Q)

Highest at USD 3,762.2 MM

OPERATING PROFIT(Q)

Highest at USD 1,149.2 MM

OPERATING PROFIT MARGIN(Q)

Highest at 30.55 %

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for Viatris, Inc.

Pre-Tax Profit
At USD 421.9 MM has Grown at 1,202.16%
over average net sales of the previous four periods of USD 32.4 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Interest Coverage Ratio
Highest at 959.27
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Pre-Tax Profit
Highest at USD 421.9 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 367.1 MM has Grown at 126.47%
over average net sales of the previous four periods of USD 162.1 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Operating Cash Flow
Highest at USD 2,330.8 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 3,762.2 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 1,149.2 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 30.55 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Cash and Eqv
Highest at USD 3,670.7 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -6.9% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Footer loading